cerrar

USA

Clinical Trial Diversity / Patient Engagement, Remote Participation & Industry Buy-In

Clinical trial diversity not only allows for a better understanding of the safety and efficacy of new therapies in population subgroups but also plays a significant role in reducing health inequities. In conversation with PharmaBoardroom, outgoing president and global chief…

Global / Top Five Most Expensive Drugs 2022

The FDA’s recent accelerated approval for Bluebird Bio’s gene therapy Skysona and its US list price of USD three million per treatment has reignited the global debate around drug pricing.…

Leadership / Most Powerful Women in Pharma 2022

Fortune’s new 50 Most Powerful Women in Business list features four representatives of Big Pharma, as well as a further four from powerful US health insurance corporations.   The annual…

Global / Four Fundamental Components of a Successful Decentralised Clinical Trial

A boom in decentralised clinical trials was an unexpected effect of the COVID-19 pandemic and subsequent lockdowns. However, these trials require expertise and technology that can differ significantly from those…

In Conversation

Clinical Trial Diversity: Patient Engagement, Remote Participation & Industry Buy-In

Clinical trial diversity not only allows for a better understanding of the safety and efficacy of new therapies in population subgroups but also plays a significant role in reducing health inequities. In conversation with PharmaBoardroom, outgoing president and global chief executive of the Drug Information Association (DIA) Barbara Lopez Kunz, speaks about the progress that has been made in increasing…

Barbara Lopez Kunz – President & Global Chief…

Clinical Trial Diversity: Patient Engagement, Remote…

Clinical Trial Diversity / Patient Engagement, Remote Participation & Industry Buy-In

Clinical trial diversity not only allows for a better understanding of the safety and efficacy of new therapies in population subgroups but also plays a significant role in reducing health…

Related Report

Clinical Trial Diversity / Patient Engagement, Remote Participation & Industry Buy-In

Clinical trial diversity not only allows for a better understanding of the safety and efficacy of new therapies in population subgroups but also plays a significant role in reducing health…

Rare Diseases / Reverse Engineering for Drug Development

Monica Weldon draws on her own experience as a rare disease patient advocacy group CEO to outline how such groups can work collaboratively with other stakeholders in drug development to…

Mallinckrodt / Scandal-Hit Firm Emerges from Bankruptcy with New CEO & Strategic Plan

US generics giant Mallinckrodt, which declared bankruptcy in 2020 after a stream of litigation regarding its role in the opioid epidemic and underpaying Medicaid rebates for its drug Acthar, has…

Global / Chirfi Guindo Comes Home to Merck after Biogen Parenthesis

As of July 1st, long-term Merck alumni, Chirfi Guindo, will be returning to the company to lead Human Health Marketing as chief marketing officer for Merck Human Health and will…

USA/ FDA’s Califf Links Low US Life Expectancy to Misinformation

After US life expectancy fell for a second consecutive year, FDA Commissioner, Dr Robert M. Califf, speaking at the recent 2022 Biotechnology Innovation Organization (BIO22) International Convention, discussed what he…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here